Impact of polymorphism in sulfotransferase gene on the risk of lung cancer

Cancer Genetics and Cytogenetics

Volumn 171, Issue 1, 2006, Pages 39-43

  Pachouri, Suparna S ^a   Sobti, Ranbir Chander ^a   Kaur, Pushpinder ^a   Singh, Jagmohan ^a   Gupta, S K ^b  

^a PANJAB UNIVERSITY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

SULFOTRANSFERASE;

ARTICLE; BLOOD SAMPLING; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

ALLELES; ARYLSULFOTRANSFERASE; CASE-CONTROL STUDIES; GENE FREQUENCY; GENOTYPE; INDIA; LOGISTIC MODELS; LUNG NEOPLASMS; MULTIVARIATE ANALYSIS; MUTATION, MISSENSE; ODDS RATIO; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

NICOTIANA TABACUM;

EID: 33750317423     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.06.017     Document Type: Article

References (30)

1. Kenji S., Colin D., Mathers C., Boschi P., Alan, Lopez D., and Christopher J.L.M. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2 (2002) 37
2. Descriptive Epidemiology Production Group (DEP). CANCERMondial. GLOBOCAN 2002 [Internet database]. Lyon, France: International Agency for Research on Cancer. Available at: http://www-dep.iarc.fr/ Accessed September 28, 2006.
3. Shopland D.R., Eyre H.J., and Pechacek T.F. Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States?. J Natl Cancer Inst 83 (1991) 1142-1148
4. Hecht S.S. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res 424 (1999) 127-142
5. Turesky R.J. The role of genetic polymorphisms in metabolism of carcinogenic heterocyclic aromatic amines. Curr Drug Metab 5 (2004) 169-180
6. Coughtrie M.W., Sharp S., Maxwell K., and Innes N.P. Biology and function of the reversible sulfation pathway catalysed by human sulfotransferase and sulfatases. Chem Biol Interact 109 (1998) 3-27
7. Banoglu E. Current status of the cytosolic sultotransferases in the metabolic activation of promutagens and procarcinogens. Curr Drug Metab 1 (2000) 1-30
8. Ozawa S., Chou H.C., Kadlubar F.F., Nagata K., Yamazoe Y., and Kato R. Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by cDNA-expressed human and rat arylsulfotransferase. Jpn J Cancer Res 85 (1994) 220-228
9. Chou H.C., Lang N.P., and Kadlubar F.F. Metabolic activation of the N-hydroxy derivative of the carcinogen 4-aminobiphenyl by human tissue sulfotransferases. Carcinogenesis 16 (1995) 413-417
10. Surh Y.J., and Tannenbaum S.R. Sulfotransferase-mediated activation of 7,8,9,10-tetrahydro-7-ol, 7,8-dihydrodiol, and 7,8,9,10-tetraol derivatives of benzo[a]pyrene. Chem Res Toxicol 8 (1995) 693-698
11. Arlt V.M., Glatt H., Muckel E., Pabel U., Sorg B.L., Schmeiser H.H., and Phillips D.H. Metabolic activation of the environmental contaminant 3-nitrobenzaanthrone by human acetyltransferases and sulfotransferase. Carcinogenesis 23 (2003) 1937-1945
12. Willey J.C., Coy E., Brolly C., Utell M.J., Frampton M.W., Hammersley J., Thilly W.G., Olson D., and Cairns K. Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells. Am J Respir Cell Mol Biol 14 (1996) 262-271
13. Vietri M., Pietrabissa A., Mosca F., Spisni R., and Pacifici G.M. Curcumin is a potent inhibitor of phenol sulfotransferase (SULT1A1) in human liver and extrahepatic tissues. Xenobiotica 33 (2003) 357-363
14. Raftogianis R.B., Wood T.C., Otterness D.M., Van Loon J.A., and Weinshilboum R.M. Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 239 (1997) 298-304
15. Song W.C., Qian Y., and Li A.P. Estrogen sulfotransferase expression in the human liver: marked interindividual variation and lack of gender specificity. J Pharmacol Exp Ther 284 (1998) 1197-1202
16. Ozawa S., Tang Y.M., Yamazoe Y., Kato R., Lang N.P., and Kadlubar F.F. Genetic polymorphisms in human liver phenol sulfotransferase involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. Chem Biol Interact 109 (1998) 237-248
17. Adjei A.A., Prondzinski J.E., Olson J.E., Vierkant R.A., Pankratz V.S., Frederickson Z.S., Sellers T.A., and Weinshilboum R.A. SULT1A1 5′-flanking region polymorphisms and breast cancer risk in the Minnesota Breast Cancer Family Study. [Abstract]. Proc Am Assoc Cancer Res 44 (2003) 1249
18. Coughtrie M.W.H., Gilissen R.A.H.J., Shek B., Strange R.C., Fryer A.A., Jones P.W., and Bamber D.E. Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem J 337 (1999) 45-49
19. Carlini E.J., Raftogianis R.B., Wood F.C., Jin F., Zheng W., Rebbeck T.R., and Weinshilboum R.A. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics 11 (2001) 57-68
20. Nowell S., Ambrosone C.B., Ozawa S., Macleod S.L., Mrackova G., Williams S., Plaxco J., Kadlubar F.F., and Lang N.P. Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol. Pharmacogenetics 10 (2000) 789-797
21. *1 genotype is associated with reduced risk of colorectal cancer. Pharmacogenetics 11 (2001) 679-685
22. Wang Y., Spitz M.R., Tsou A.M.H., Zhang K., Makan N., and Wu X. Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. Lung Cancer 35 (2002) 137-142
23. Wu M.T., Wang Y.T., Ho C.K., Wu D.C., Lee Y.C., Hsu H.K., Kao E.L., and Lee J.M. SULT1A1 polymorphism and esophageal cancers in males. Int J Cancer 103 (2003) 101-104
24. Ozawa S., Katoh T., Inatomi H., Imai H., Kuroda Y., Ishiba H., and Ohno Y. Association of genotypes of carcinogen-activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N-acetyltransferase 2 NAT2, with urothelial cancer in a Japanese population. Int J Cancer 102 (2002) 418-421 [Erratum in: Int J Cancer 2003;104:798]
25. Tang D., Rundle A., Mooney L., Cho S., Schnabel F., Estabrook A., Kelly A., Levine R., Hibshoosh H., and Perera F. Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case-control study. Breast Cancer Res Treat 78 (2003) 217-222
26. Saintot M., Malaveille C., Hautefeuille A., and Gerber M. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyl transferase and tobacco exposure in breast cancer risk. Int J Cancer 107 (2003) 652-657
27. Lilla C., Risch A., Kropp S., and Chang-Claude J. SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case-control study. Breast Cancer Res 7 (2005) R229-R237
28. Liang G., Miao X., Zhou Y., Tan W., and Lin D. A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking. Carcinogenesis 25 (2004) 773-778
29. Roe BA, Crabtree JS, Khan AS (editors). Methods for DNA isolation. Part III. In: Protocols for recombinant DNA isolation, cloning, and sequencing [Internet edition]. Norman, OK: University of Oklahoma; Aug. 5, 1995. Available from: http://www.genome.ou.edu/protocol_book/protocol_index.html; also available in paper copy as: DNA isolation and sequencing; New York: Wiley; 1996.
30. Khuri F.R., Herbst R.S., and Fossella F.V. Emerging therapies in non-small cell lung cancer. Ann Oncol 12 (2001) 739-744